Beneficial effects of atrial fibrillation ablation in patients with angina pectoris and coronary sinus reducer. Issue 1 (12th October 2021)

• Record Type: Journal Article
• Authors: Khalaph, Moneeb; Bergau, Leonard; Vanezi, Maria; Rudolph, Tanja K.; Sommer, Philipp; Sohns, Christian
• Is Part Of: Pacing and clinical electrophysiology. Volume 45:Issue 1(2022)
• Page Start: 149
• Page End: 153
• Publication Date: 2021-10-12
• Subjects: angina pectoris -- atrial fibrillation -- coronary sinus reducer -- substrate modification; Cardiac pacing -- Periodicals; Electrophysiology -- Periodicals; 617.4120645
• DOI: 10.1111/pace.14367
• Languages: English
• ISSNs: 0147-8389

Abstract

Abstract: Limited data exists about the effectiveness of the coronary sinus reducer (CSR) device in patients with angina pectoris and atrial fibrillation (AF). This case demonstrates beneficial effects of AF ablation in a patient with CSR. We report four major findings: Rhythm control has a relevant effect on angina pectoris symptoms in patients with coronary artery disease and AF. In these patients, AF ablation should be considered at an early stage. Patients with persistent angina pectoris and CSR may require sinus rhythm for an optimal effect of the device. Selected coronary sinus (CS) interventions can still be performed through the mesh of the CSR device.